Shares in Protolabs (NYSE: PRLB) dropped by 12.4% today on news of weak fourth-quarter demand. Sales met analysts’ expectations, but profits fell sharply compared with the fourth quarter of 2018.
The Maple Plain, Minn.-based rapid manufacturing company reported profits of $15.19 million or $0.63 per share, on sales of $111.89 million for the three months ended Dec. 31, 2019, for a bottom-line drop of -21.3% on a sales shrinkage of -0.07% compared with Q4 2018.
Get the full story on our sister site, Medical Design & Outsourcing.